Clinical Trial

Efficacy and Safety of Topical Tranexamic Acid (TXA) Administration Cementless Bipolar Hemiarthroplasty for Femoral Neck Fracture - a Randomized Controlled Trial

Study acronym: TXA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this Randomized controlled trial is to evaluate in household ambulatory, elderly patients sustaining femoral neck fracture who are subjected to be treat with cementless bipolar hemiarthroplasty. The main questions it aims to answer are: * The efficacy in reducing blood transfusion for topical tranexamic acid administration * The safety of tranexemic acid, topically used As having undergone bipolar hemiarthroplasty surgery, participants will either receive retrograde intraarticular tranexamic acid injection via drain tube, or topical soaking administration. Researchers will compare, with standard procedure (procedure), whether topically administered tranexamic acid would reduce rate of blood transfusion.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04 -> 2026-08-31 2026-08-06
minor Completion pushed: 2026-04 -> 2027-06-30 2026-08-06
Trial Details
NCT Number NCT06289478
Lead Sponsor King Chulalongkorn Memorial Hospital
Conditions Femoral Neck Fracture
Enrollment 75 participants
Start Date 2024-07-03
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05